Apple has posted a video on YouTube featuring the implementation of iOS devices at the Geisinger Health System a health care system with locations in northeastern and central Pennsylvania. See: Geisinger and Apple – Empowering Patients and Reimagining Hospital Care
TechCrunch is reporting that Jawbone is preparing to exit the low-margin fitness bands market sold directly to consumers, to focus on the high-margin business to business to consumer model, Specifically, enterprise medical devices and associated services sold directly to clinicians and health providers working with patients.
MobiHealthNews opines that Jawbone is working on their clinically-focused wearable, building on their 2015 acquisition of Spectros. Spectros specialized in application of spectroscopy in non-invasive molecular sensors for use in pulse oximetry and detection of perfusion and ischemia. Spectros, was a startup founded by Jawbone’s Chief Medical Officer David Benaron.
Jawbone is currently seeking additional funding to support their new initiative. Another entry into the lucrative wearable medical device marketplace.
For more information see:
The American Bar Association Commission on Law and Aging has announced that effective in early September 2016, the ABA will no longer be selling or supporting its $3.99 My Health Care Wishes Pro app. Due to reasons of financial sustainability, the app will be removed from both the iTunes and Google Play iStores as of September 3rd, 2016.
A free alternative app is Stanford Medicine’s Advance Directive app. See here fore more information about the project: Doctor’s Note for End-of-Life Care and here for the app: Stanford Letter Project App on the App Store
This week Apple announced their acquisition of Gliimpse™, a personal health startup. In their LinkedIn profile Gliimpse™ notes that they began with a simple idea – everyone should be able to manage their health records, and share them securely with those they trust. Another technologic opportunity to improve patient engagement.
The Wall Street Journal reports that the services of Gliimpse™ are free to consumers, with healthcare providers and developers paying for its data-sharing software and services. The Journal opines that this acquisition provides the opportunity for Apple to build a platform for electronic medical records.
Although it is presently unclear what Apple has planned for this acquisition, it joins Apple’s other healthcare related apps HealthKit and ResearchKit.
TempTraq is an intelligent thermometer that continuously senses, records, and sends alerts of a child’s temperature to a iOS or Android mobile device. Once activated, the TempTraq wearable patch is active for a continuous 24-hour period of time allowing for one full day of temperature monitoring. The associated app displays both real time and historical temperature data transmitted from the patch in graphical and data table views. The wearable patch transmits data via Bluetooth to the app via Bluetooth. One significant negative about this device is it’s cost of $24.99 for a single 24 hour use device.
The D-EYE Portable Eye and Retinal Imaging System attaches to an iOS or Android smartphone, creating a fundus camera for health screening and evaluation. This portable ophthalmoscope is capable of recording and transmitting high-definition images and video of the eye. The D-EYE describes the simple process to use the digital ophthalmoscope: just download the smartphone app, affix the mounting bumper and D-EYE lens, set up patient exam file, focus the phone’s camera and begin recording.
Medgadget has a great interview with Dr. Andrea Russo, the inventor of the D-EYE at http://www.medgadget.com/2015/05/d-eye-low-cost-digital-ophthalmoscope-smartphone-interview.html
For more information:
Today we have another example of iOS devices being used in medicine. St. Jude Medical has announced the Invisible Trial System External Pulse Generator (EPG), an external device that provides spinal cord stimulation (SCS) as an aid in the management of chronic, intractable pain of the trunk and limbs. This SCS on-body trial system is designed to mimic the experience of a permanent implant, eliminating the necessity for a trial cable.
The Clinician Programmer App enables the clinician to program the EPG and the Patient Controller App utilizes an iPod touch to control the device. Both apps and devices communicate with the EPG via Bluetooth.
For more information: